Where does Medtronic Urinary Solutions, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Medtronic Urinary Solutions, Inc. ranks #32,469 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Medtronic Urinary Solutions, Inc. hold?

Medtronic Urinary Solutions, Inc. holds 8 US utility patents granted between 2015 and 2019, spanning 5 technology areas.

What is Medtronic Urinary Solutions, Inc.'s Innovation Score?

Medtronic Urinary Solutions, Inc. has an Innovation Score of 29.1 out of 100 (29th percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Medtronic Urinary Solutions, Inc. focus on?

Medtronic Urinary Solutions, Inc.'s top technology area is A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy) with 8 patents, ranking #457 of 1,943 assignees active in that subclass. Grants appear in 5 CPC subclasses total.

Is Medtronic Urinary Solutions, Inc.'s patent grant rate increasing or decreasing?

Medtronic Urinary Solutions, Inc.'s recent grant velocity is -100% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Medtronic Urinary Solutions, Inc.'s patents?

Medtronic Urinary Solutions, Inc.'s patents average 22.6 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Medtronic Urinary Solutions, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Medtronic Urinary Solutions, Inc.

USPTO PatentsView assignee record - 8 granted patents across 5 technology areas, recorded in grant years 2015–2019. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Medtronic ranks #32,469 of 49,997 tracked US assignees by granted-patent volume, with 8 patents across 5 technology areas.

#32,469
of 49,997 US assignees by volume: 29th percentile
by Innovation Score (29.1/100): 22.6
avg claims per patent: -100%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R32469 · US Corporation #32,469 · 8 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-DENSE · TYPE-USCORP · VEL-DROP · BOOK-FULL

GRANTS-MICRO 8 grants
MID-PACK #32,469/49,997
PHOTO-FINISH Medial Research
CPC-NARROW A61N · 5 areas
INNOV-THIN 29.1/100
CLAIMS-DENSE 22.6 claims/avg
TYPE-USCORP US Corporation
VEL-DROP -100% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Medial Research Ltd. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Medtronic’s 29.1 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 7.6 pts (26%) Velocity 0.0 pts (0%) Breadth 7.9 pts (27%) Claim depth 13.6 pts (47%)

Qualcomm Incorporated · highest

85
Medtronic Urinary… · this assignee

29
3D Lighting… · lowest

7

What this shows Medtronic's Innovation Score is 29.1/100 (29th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Medtronic?

Each dot is one of Medtronic’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Medtronic’s own 22.6 claims/patent is ABOVE the 17.6 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Medtronic vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Medtronic's grants concentrate

Medtronic Urinary Solutions, Inc. is a focused PatentsView assignee: 5 CPC subclasses with 100% of grants classified under A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy). Peak complete grant year is 2019 (3 grants) versus a trough of 1 in 2017. By volume, Medtronic sits between Medial Research Ltd. and Meggitt Aircraft Braking Systems Corporation.

Medial Research

8
Medica Medizintec…

8
Medizinische Univ…

8
Medtronic 3F Ther…

8
Megaphase

8
Megger Instruments

8
Meggitt (Orange C…

8
Meggitt Aircraft…

8
Medtronic Urinary… ◀

8

What this shows Medtronic holds 8 patents at rank #32,509, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Medtronic

By rank, the assignees closest to #32,509 in granted patent volume.

Leaders in A61N (Electrotherapy)

Other assignees with the most granted patents in Medtronic's primary technology class.

Medtronic's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

29 29th percentile higher than 29% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2019

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Medtronic Urinary Solutions, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	2	25.0%
2016	2	25.0%
2017	1	12.5%
2019	3	37.5%

Which technologies does Medtronic Urinary Solutions, Inc. patent most?

A61N - ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy 8

G16H - Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data 3

G08C - Transmission Systems FOR Measured Values, Control OR Similar Signals 2

H04W - Wireless Communication Networks 2

H02J - Circuit Arrangements OR Systems FOR Supplying OR Distributing Electric POWER; Systems FOR Storing Electric Energy 2

Top 5 of 5 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Medtronic Urinary Solutions, Inc.'s patent record in context - here's where to go next.

Medtronic Urinary Solutions, Inc.'s lead technology class is A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy), 100% of its portfolio - see every assignee active in that class. Explore A61N
Ranked #32,469 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Medtronic Urinary Solutions, Inc. against Medial Research Ltd., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 29.1/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.